Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Austrian Post 5.49 € DPD courier 3.99 € DPD point 2.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Anticancer Drug Development Guide

Name: Anticancer Drug Development Guide
Brand: Springer-Verlag New York Inc.
SKU: 02269490
Price: 107.29 EUR
Availability: InStock
Author: Beverly A. Teicher
ISBN: 9781461581543

Preclinical Screening, Clinical Trials, and Approval

Beverly A. Teicher

Language

English

Book Paperback

Libristo code: 02269490

Publishers Springer-Verlag New York Inc., June 2013

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia... Full description

Libristo code: 02269490

263 b

107.29 € VAT included

In stock at our supplier Shipping in 5-8 days

Delivery to Austria

30-day return policy

Customers also purchased

Übungsfragen Biologie Hans B. Strack

Paperback

55.29 €

Follies of Essex Gwyn Headley E-book

Adobe ePub DRM

4.29 €

Un experiment de crítica literaria C S Lewis

Paperback

21.29 €

Divoké prase

Toy

6.89 €

Válka a její strašlivá láska James Hillman

Sheet

13.39 €

Hledání zázračného P.D. Uspenskij

Paperback

14.19 €

Gemeinsam Singen Wir Tiroler Lieder Sonnalp Trio

Audio CD

16.39 €

Demokratie heute - Ausgabe 2015 für Niedersachsen, m. 1 Buch, m. 1 Online-Zugang Dieter Deiseroth

Hardback

32.29 €

Basische Kost Doris Wroblewski

Paperback

14.50 €

Experienced cancer researchers from pharmaceutical companies, government laboratories, and academia comprehensively review and describe the arduous process of cancer drug discovery and approval. They focus on using preclinical in vivo and in vitro methods to identify molecules of interest, detailing the targets and criteria for success in each type of testing and defining the value of the information obtained from the various tests. They also define each stage of clinical testing, explain the criteria for success, and outline the requirements for FDA approval. A companion volume by the same editor (Cancer Therapeutics: Experimental and Clinical Agents) reviews existing anticancer drugs and potential anticancer therapies. These two volumes in the Cancer Drug Discovery and Development series reveal how and why molecules become anticancer drugs and thus offer a blueprint for the present and the future of the field.